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Summary When an antitumour mannoglucan prepared from Microellobosporia grisea, MGA was
administered i.v. to C3H/He mice bearing the solid MH134 hepatoma, a cytotoxic factor was induced that
was detectable in the tumour homogenate by an 8 h cytolysis assay against L-929 fibroblasts. Without MGA
treatment, the cytotoxic factor was not detectable in the tumour homogenate. MGA induced the cytotoxic
factor in tumour tissue specifically, its level reaching a maximum (24Uml-1) 3h after administration of
MGA: little if any cytotoxic factor was detectable in homogemates of normal tissues or sera after MGA-
treatment. The molecular size of the cytotoxic factor was estimated to be 70-80kD by gel filtration. It seemed
to be a type of tumour necrosis factor because its activity was inhibited by antiserum against murine tumour
necrosis factor. From these results, the selective induction of the cytotoxic factor was concluded to be
important in the mechanism of the antitumour activity of MGA.
Cytotoxic factors to tumour cells, such as tumour necrosis
factor (TNF) can be induced in sera endogenously by some
conjugated polysaccharides (Carswell et al., 1975; Takahashi
et al., 1985). Induction of the cytotoxic factor (CF) is
thought to be related to the antitumour activities of the
polysaccharides. However, CF activity has been mainly
examined in sera, but its activity in tumour tissues is likely
to be more biologically relevant for antitumour mechanisms.
In fact, it has been shown that TNF is effective at a lower
dose when injected into tumours than when injected
systemically (Gatanaga et al., 1985).
Studies are in progress in our laboratory on the anti-
tumour and immunomodulating activities of purified manno-
glucans prepared from the actinomycetes Microellobosporia
grisea (Inoue et al., 1983). These mannoglucans, which have
a unique, tetrasaccharide repeating-unit structure, have
molecular weights of about 3-10 x 102 kD and show anti-
tumour activity without detectable side effects (Nakajima et
al., 1984). In preceding papers, we reported that MGA, a
polyalcoholized mannoglucan, caused tumour ischaemia
(Abe et al., 1985) and rapid and definite growth inhibition of
the MH134 hepatoma in C3H/He mice (Abe et al., 1984). In
studies on the antitumour mechanism of MGA, we
investigated CF induction in murine tumours. Here we show
that on systemic administration, MGA selectively induced
TNF-like CF in tumour tissues.
Materials and methods
Mice and tumour
Inbred male C3H/He mice were purchased from Shizuoka
Agricultural Cooperative Association for Laboratory
Animals, Hamamatsu. They were 7-9 weeks old at the
beginning of the experiments. MH134, a transplantable
ascites hepatoma, was passaged weekly in the peritoneal
cavity of C3H/He mice.
Agents
A polyalcoholized mannoglucan, MGA (mol. wt3-10 x
102 kD) was kindly provided by Daiichi Seiyaku Co., Ltd.,
Tokyo. Lipopolysaccharide (LPS) from E. coli 0127, B8 was
purchased from Difco Lab. (Detroit, Mich.), Rabbit (Ruff
et al., 1980) and mouse (Carswell et al., 1975) tumour
necrosis ser-um (TNS) was prepared as described previously.
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The murine TNS was partially purified by the method of
Haranaka et al. (1986) in our laboratory.
Cell line
L-929, a transformed cell line originally derived from a C3H
strain mouse, was grown in Eagle's minimum essential
medium (MEM; Nissui Seiyaku Co., Tokyo, Japan)
supplemented with 5% foetal calf serum (FCS; GIBCO
Laboratories, Grand Island, NY, USA) and passaged every
3 or 4 days.
Preparation ofcytotoxicfactors
Inocula of 2.0 x 105 cells of MH134 hepatoma were injected
i.d. into the abdomen of C3H/He mice (day 0). Tumours
developed within a few days after the inoculation and
reached 6-8 mm diam. on day 7. The mice were then treated
i.v. with MGA (2.0mg/mouse) in 0.2ml saline. Animals were
bled to obtain serum, usually 3h later, and their tumour and
other tissues resected. Tissues from groups of at least 3 mice
were weighed, minced with fine scissors and homogenized in
PBS containing 20% of FCS (1.0ml/0.3 g wet tumour tissue)
for 20 sec in a polytron (Kinematika, Switzerland) at a
power setting of 5 in test tubes. The homogenates were
centrifuged for 5min at 900g, and the cloudy supernatants
recentrifuged for 1 h at 100,OOOg to obtain clear super-
natants. The samples were then promptly subjected to
chromatography or stored at -80°C. All experiments were
performed within 1 week of isolation of tissues.
Cytotoxic assay
The cytotoxic activity of test samples was measured by in
vitro cytotoxic assay with L-929 cells as targets (Ruff et al.,
1980) as described previously (Satoh et al., 1986). The
cytotoxic activity was calculated as mean of the ratio of the
dilution of the test sample required to induce 50% killing of
L-929 cells (ED50) to that of standard rabbit TNS
(6 x103Uml-1). The ED50 value of standard rabbit TNS
was 105-10-55 in all the present experiments. CF was
detectable at a level of more than 0.1 Uml
Chromatographic procedure
The supernatant of tumour tissue homogenates or partially
purified murine TNF (mTNF) was loaded onto a TSK-3000
SW column (0.75 x 60cm) connected to a high performance
liquid chromatography (HPLC) system (Shimazu, LC-6A
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model). Material was eluted with PBS, pH7.2. Fractions of
500MI were obtained at a flow rate 60mlh-1. Bovine serum
albumin (67kD), ovalbumin (45 kD) and myoglobin (17kD)
were chromatographed separately as mol. wt markers.
Inhibition by anti-murine TNF serum
Anti-murine TNF (anti-mTNF) rabbit serum was provided
by Dr M. Tsujimoto. The anti-mTNF serum was made
against murine recombinant TNF (Kawakami et al., 1987).
Mixtures of 20 ul normal rabbit serum or anti-mTNF serum
and 180pl of supernatant containing CF or 103 fold
dilutions of mTNF were incubated for 5h at 4°C. The
mixture was centrifuged at 6,000g for 5min, and cytotoxic
activity against L-929 cells measured.
Results
Cytotoxic activity in tumour-homogenates obtainedfrom
MGA-treated mice
MH134 hepatomas inoculated i.d. into C3H/He mice are
very susceptible to MGA treatment, especially when adminis-
tered 7 days after tumour inoculation (Abe et al., 1984,
1985). Following MGA treatment, the blood circulation in
tumour tissues is inhibited within 6h (Abe et al., 1985) and
tumour growth retarded within 3 days (Abe et al., 1984). Using
this system, we searched for cytotoxic factors induced
by MGA in tumour tissues.
Cytotoxic activity was measured in the clear supernatants
obtained by centrifugation of homogenates of tumour
tissues. As seen in Figure 1, the supematants of homogenates
of MH134 tumour tissues from MGA-treated mice showed
dose-dependent cytotoxicity to L-929 cells, but similar
preparations from untreated mice did not, indicating that
MGA induced a cytotoxic factor (CF) in turnour tissues. The
dose-response pattern of the CF was similar to that of rabbit
tumour necrosis serum prepared by a conventional method
(Ruff et al., 1980). This similarity suggested that the CF in
tumour tissues and TNF might have similar cytotoxic
activity. To examine the recovery of the CF during sample
preparation, a known quantity (170 units) of murine-TNF
was added to the tumour tissues before their homogenization
and the cytotoxic activity in the final supernatants measured.
The cytotoxic activity of murine-TNF was recovered
completely (data not shown).
The time course of CF induction in tumour-tissues was
examined after MGA administration to the mice. CF activity
in tumour tissues was detectable after 1 h, and maximal after
3 h, and decreased by 6h after MGA administration (Figure
2). Therefore in subsequent experiments, CF activity was
usually measured 3 h after MGA administration.
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Figure 1 Cytotoxic activity in supernatants prepared from
MH134-tumours of MGA-treated mice. MGA (2.0mg/mouse;
0) was administered i.v. on day 7 after i.d. inoculation of
MH134 hepatoma (2.0 x 105 cells). Controls (0) received no
MGA. Tumours were resected 3 h later. Supernatants of tumour
homogenates were prepared and their cytotoxic activity measured
against L-929 cells. Control rabbit TNS (-). Experimental details
as in Materials and methods.
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Figure 2 Time course of CF induction after MGA adminis-
tration. MGA (2.0mg/mouse) was administered i.v. on day 7
after i.d. inoculation of MH134 hepatoma (2.0 x 105 cells).
Tumours were resected 0, 0.5, 1, 3, or 6h later and the cytotoxic
activity of their supernatant measured.
Figure 3 shows the dose-response of CF activity to MGA
injected i.v. into tumour-bearing mice. The CF in tumour
tissues was detectable after injection of MGA at 5,ug/mouse
and maximal after injection of 100-2,000 yg/mouse.
Selective induction of CF in tumour tissues
Previously we reported that TNF-like CF was induced in
sera (Takahashi et al., 1985). Here, we examined the tissue
selectivity of CF induction in tumour-bearing mice. Table I
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Figure 3 Dose-response to MGA of CF induction. Mice were
treated i.v. with 0, 0.1, 5, 100, or 2,000pg MGA on day 7 after
i.d. inoculation of MH134 hepatoma (2.0 x105 cells), and the
cytotoxic activity in their tumour supernatant measured 3 h later
as described in Materials and methods.
Table I Selective induction of CF in tumour tissues
Cytotoxic activity
(units ml- )a
MGAb LPS
Sample I hc 3h 2h 3h
Exp. 1 Tumour 2.3 8.0 <0.1
Serum 0.2 <0.1 0.4
Skin 1.6 0.2
Muscle <0.1 <0.1
Exp. 2 Tumour 1.5 3.2
Liver <0.1 <0.1
Spleen <0.1 <0.1
Lung <0.1 <0.1
Exp. 3 Tumour 13.4 <0.1
Serum <0.1 <0.1
'Cytotoxic activity in supernatants prepared from
each tissue or serum measured as described in text;
bMGA (2.0mg/mouse) or LPS (1.0gg/mouse) was
injected i.v. into tumour-bearing mice on day 7 after
i.d. inoculation of MH134 hepatomas (2.0 x 105 cells);
CHours between administration of MGA or LPS and
time of examination; Similar results were obtained in
two other experiments under the same conditions.
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shows that CF was induced in tumour tissues. Small
amounts of CF were also detectable in sera, skin and lung
tissues, but not in muscle, liver or spleen tissues. Thus MGA
induced CF activity in selective sites in tumour-bearing mice.
For comparison with MGA, the efficacy of lipopoly-
saccharide (LPS), which induces TNF in sera within 2h of
i.v. injection into mice primed with Bacillus Calmette-Guerin
(Takahashi et al., 1985) was tested. LPS induced a low level
of CF in the serum, but not in tumour tissues under these
conditions (Table I).
Characterization ofCF induced in tumour tissues
The CF induced in tumour tissues was partially charac-
terized and compared with mTNF, which was induced in
sera by a conventional method (Carswell et al., 1975). Figure
4 shows the profile of the CF from tumour tissues on gel
filtration (TSK-3000 SW), from which the molecular size was
estimated to be 7080 kD. CF activity in murine TNF,
examined as a control, was recovered in the same fractions
as CF from tumour tissues (Figure 5).
The antigenicity of the CF was examined with anti-mTNF
serum. Table II shows that the CF activity was inhibited by
anti-mTNF serum. Therefore, this CF was characterized as a
TNF-like cytotoxic factor.
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Figure 4 Gel filtration of MGA-induced CF. 100j1u supernatant
containing CF prepared from MH134-tissues of MGA-treated
mice was applied to a TSK-3000 SW column. The cytotoxic
activity of each fraction is expressed as the survival ratio of L-
929 cells (0). Bovine serum albumin (57kD), ovalbumin
(43 kD), and myoglobin (17kD) were used as mol. wt markers.
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Figure 5 Gel filtration of murine TNF. For details see footnote
to Figure 4. Cytotoxic activity was tested in each fraction after
500-fold dilution in PBS.
Table II Inhibition of CF activity by anti-mTNF
serum
Cytotoxic activity
(units ml-1)b
Mouse
Treated witha CF TNF
Medium 17.7 7.4
Anti-mTNF rabbit serum <0.1 <0.1
Normal rabbit serum 15.4 8.1
aTwenty jul of normal rabbit serum or anti-mTNF
serum was added to test samples (180,l) before
cytotoxic assay, as described in Materials and methods;
bSee footnote to Table I.
Discussion
It has been shown herein that systemic administration of
MGA induces a TNF-like CF selectively in tumours. This
CF was concluded to be a type of TNF from the following
three observations: (i) The dose-dependences of the cyto-
toxicities of CF and rabbit TNF against L-929 cells were
similar (Figure 1). (ii) The molecular sizes of the CF and
murine TNF were both estimated to be 70-80 kD (Figure 4).
(iii) The activity of the CF was inhibited by anti-mTNF
serum (Table II). The mol. wt of murine TNF has been
estimated by gel filtration to be - 40kD (Haranaka et al.,
1986) and - 70-80kD (Beutler et al., 1985; Kull et al., 1984);
our results are concordant with the latter. The different
estimates of the molecular size of murine TNF may be
attributable to differences in the conditions of gel filtration.
In the present experiments, gel filtration was performed
using the same type of HPLC column and buffer as those of
Kull et al. (1984).
LPS is known to induce TNF in sera (Carswell et al.,
1975; Takahashi et al., 1985). Actually, we found that it
induced a low level of serum TNF activity (Table I). By
contrast, MGA induced TNF-like CF selectivity in particular
sites. After i.v. administration of MGA, the CF of tumour
tissues reached a maximum, 24Ug-1 of tumour (wet wt) in
3h whereas the CF activities of the skin, lung, liver, spleen
and muscle tissues and sera, were low or negligible. This
selective induction of the CF in tumour tissues is a charac-
teristic of MGA.
The mechanism of this selective effect of MGA is now
being examined. There are several types of inflammatory
host cells (e.g., polymorphonuclear leukocytes, macrophages)
in solid tumours and their functional status in tumour tissues
and other anatomical regions may be different (reviewed by
Evans, 1982). It is therefore not surprising that the CF was
induced selectively in tumours. The selective induction of the
CF could be caused by natural inflammatory actions at the
site of growing tumours. This speculation is supported by
our preliminary finding (unpublished data) that following
i.d. injection of non-tumorous inflammatory agents, systemic
administration of MGA induced the CF preferentially in
skin tissues.
The in vivo significance of the local induction of cytotoxic
factors by MGA should be clarified. MGA treatment
increased the level of cytotoxic factor in tumours to-20-
30Ug-1. We have reported that when injected intra-
tumorally, a small dose (60 units/mouse) of partially purified
rabbit TNF was effective in inhibiting the growth of MH134
hepatoma (Gatanaga et al., 1985). So, 20-30Ug-1 CF in
tumours would be expected to have some inhibitory effect.
MGA caused infiltration of polymorphonuclear leukocytes
into tumours and inhibited the blood flow in capillaries in
the tissue within 6h of administration, with arrest of tumour
growth (Abe et al., 1985). Similar phenomena were reported
as responses of tumours to injection of exogenous TNFCYTOTOXIC FACTOR IN TUMOUR TISSUE 173
(Balkwill et al., 1986). So, it is hypothesized that a part of
the antitumour activity of MGA is the induction of CF in
tumours as well as the other immunopharmacological effects
of MGA (Nakajima et al., 1984b) such as augmentation of
the cytotoxic activity of macrophages, NK cells and killer
cells and the induction of interleukin I and colony
stimulating factors.
The in situ induction of a TNF-like cytotoxic factor in
tumours by MGA provides a novel approach to tumour
treatment with a potential for improved therapeutic efficacy
and minimal systemic toxicity (Oshima et al., 1986).
We thank Prof. Den'ichi Mizuno (Teikyo University) for support
and encouragement; Daiichi Seiyaku Co., Tokyo, for providing
MGA; Dr Masafumi Tsujimoto for providing anti-murine TNF
rabbit serum and Dr Motonobu Satoh and Katsunori Adachi for
providing partially purified murine TNF.
References
ABE, S., TAKAHASHI, K., TSUBOUCHI, J., AIDA, K., YAMAZAKI, M.
& MIZUNO, D. (1984). Different local therapeutic effects of
various polysaccharides on MH134 hepatoma in mice and its
relation to inflammation induced by the polysaccharides. Gann,
75, 459.
ABE, S., TAKAHASHI, K., YAMAZAKI, M. & MIZUNO, D. (1985).
Ischemic reaction in murine tumour tissues inducing by
mannoglucan-polyalcohol (MGA). Proc. Jpn. Pharm. Assoc.,
105th Ann. Mtg, p. 271 (in Japanese).
BALKWILL, F., LEE, A., ALDAM, G. & 4 others (1986). Human
tumour xenografts treated with recombinant human tumor
necrosis factor alone or in combination with interferons. Cancer
Res., 46, 3990.
BEUTLER, B., GREENWALD, D., HULMES, J.D. & 5 others (1985).
Identity of tumor necrosis factor and the macrophage-secreted
factor cachetin. Nature, 316, 552.
CARSWELL, E.A., OLD, L.J., KASSEL, R.L., GREEN, S., FIORE, N. &
WILLIAMSON, B. (1975). An endotoxin-induced serum factor
that causes necrosis of tumors. Proc. Natl Acad. Sci. USA, 72,
3666.
EVANS, R. (1982). Macrophages and neoplasms: New insights and
their implication in tumor immunology. Cancer Metast. Rev., 1,
227.
GATANAGA, T., TAKAHASHI, K., YAMAZAKI, M., MIZUNO, D. &
ABE, S. (1985). Combination antitumor therapy with rabbit
tumor necrosis factor and chemo- and immuno-therapeutic
agents against murine tumors. Jpn. J. Cancer Res. (Gann.), 76,
631.
HARANAKA, K., CARSWELL, E.A., WILLIAMSON, B.D.,
PRENDERGAST, J.S., SATOMI, N. & OLD, L.J. (1986).
Purification, characterization, and antitumor activity of non-
recombinant mouse tumour necrosis factor. Proc. Natl Acad. Sci.
USA, 83, 3949.
INOUE, K., KAWAMOTO, K. & KADOYA, S. (1983). Structural
studies on an antitumour polysaccharide from Microellobosporia
grisea. Carbohydr. Res., 114, 245.
KAWAKAMI, M., MURASE, T., OGAWA, H. & 4 others (1987).
Human recombinant TNF suppresses lipoprotein lipase activity
and stimulates lipolysis in 3T3-LI cells. J. Biochem., 101, 331.
KULL, F.C. & CUATRECASAS, P. (1984). Necrosin: Purification and
properties of a cytotoxin derived from a murine macrophage-like
cell line. Proc. Natl Acad. Sci. USA, 81, 7932.
NAKAJIMA, H., HASHIMOTO, S., NAGAO, S & 5 others (1984a).
Host-mediated antitumour effect of DMG, a degraded D-
manno-D-glucan from Microellobosporia grisea culture fluid.
Gann, 75, 253.
NAKAJIMA, H., KITA, Y., TAKASHI, T. & 6 others (1984b). Immuno-
potentiation by a new antitumour polysaccharide, DMG, a
degraded D-manno-D-glucan from Microellobosporia grisea
culture fluid. Gann, 75, 260.
OSHIMA, H., INAGAWA, H., SATOH, M., SHIMADA, Y., ABE, S.,
YAMAZAKI, M. & MIZUNO, D. (1986). Theoretical grounds and
practical methods for induction of endogenous production of
human tumor necrosis factor. In Host Defense Mechanisms
against Cancer, Urushizaki, I. et al (eds) p. 92.
RUFF, M.R. & GIFFORD, G.E. (1980). Purification and physico-
chemical characterization of rabbit tumor necrosis factor. J.
Immunol., 125, 1671.
SATOH, M., INAGAWA, H., MINAGAWA, H. & 5 others (1986).
Endogenous production of TNF in mice long after BCG
sensitization. J. Biol. Res. Modif., 5, 117.
TAKAHASHI, K., KISUGI, J., GATANAGA, T., YAMAZAKI, M., ABE,
S. & MIZUNO, D. (1985). Induction of cytotoxic factor in sera by
immunomodulators. Yakugaku Zasshi, 105, 862 ( in Japanese).